AEON Biopharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,643 | -3,991 | -7,736 | -10,356 |
EBIT | -5,666 | -4,016 | -7,760 | -10,381 |
Net Income | 2,082 | -6,171 | 164,112 | -118,018 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -621 | -2,955 | -8,116 | -8,600 |
Cash | 13 | 537 | 3,442 | 1,558 |
Basic Shares | 1,110 | 38,568 | 539 | 517 |
Annual Financials
| Values in thousands | 2024-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -27,727 | -48,361 | -7,912 |
EBIT | -27,824 | -48,429 | -7,915 |
Net Income | 42,005 | -52,556 | -55,637 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -20,292 | -35,890 | -28,603 |
Cash | 13 | 9,746 | 5,128 |
Basic Shares | 7 | 305 | 305 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $3.74 |
2024-09-30 | -$11.52 |
2024-06-30 | $5.33 |
2024-03-31 | -$0.28 |
